City

Hangzhou (1)

Rize (1)

Condition

Matrix Metalloproteinases (2)

Anticoagulant (1)

Cerebrovascular Stroke (1)

Diabetes Mellitus (1)

Intracranial Hemorrhages (1)

Melatonin (1)

Periodontitis (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Yagmur Sarac Gul (1)

Intervention

melatonin 3 mg (1)

rivaroxaban (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

matrix metalloproteinases

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diabetes, Periodontitis, Melatonin Trial in Rize (Melatonin 3 MG)

Completed

Diabetes Mellitus
+3 more

Melatonin 3 MG

Rize, Turkey

Yagmur Sarac Gul

May 18, 2023

Infarction Volume on Hemorrhagic Transformation in Ischemic

Recruiting

Cerebrovascular Stroke
+3 more

Rivaroxaban

Hangzhou, Zhejiang, China

Second Affiliated Hospital, School of Medicine, Zhejiang Univers

May 5, 2022